Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Mylan tries to fend off Teva with bigger bid for Perrigo

By: MarketWatch
Mylan NV tries to fend off Teva Pharmaceuticals overtures by making a bigger bid for Perrigo Co. in a three-ring merger circus among generic drug makers.
Related Stocks:
Macy's Mylan Perrigo Teva Pharmaceutical Industries ADR
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.